![PDF) Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease | Jiri Bronsky, Jorge Amil, Jaroslaw Kierkus, Gábor Veres, and Johanna Escher - Academia.edu PDF) Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease | Jiri Bronsky, Jorge Amil, Jaroslaw Kierkus, Gábor Veres, and Johanna Escher - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/40333028/mini_magick20190221-19344-hsnm4k.png?1550766493)
PDF) Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease | Jiri Bronsky, Jorge Amil, Jaroslaw Kierkus, Gábor Veres, and Johanna Escher - Academia.edu
![European Crohn´s and Colitis Organisation - ECCO - OP40 Analysis of clinical features associated with favourable outcomes from ustekinumab treat-to-target strategy in Crohn's Disease patients in the STARDUST trial European Crohn´s and Colitis Organisation - ECCO - OP40 Analysis of clinical features associated with favourable outcomes from ustekinumab treat-to-target strategy in Crohn's Disease patients in the STARDUST trial](https://cm.ecco-ibd.eu/cmAbstractSubmission/Content/cmabstsms/EC21/abstracts/0000000270/0000739400/Images/3671_jan_ecco_abstract_predict202103101921483159.jpg)
European Crohn´s and Colitis Organisation - ECCO - OP40 Analysis of clinical features associated with favourable outcomes from ustekinumab treat-to-target strategy in Crohn's Disease patients in the STARDUST trial
![European Crohn´s and Colitis Organisation - ECCO - OP35 Effect of maintenance ustekinumab on corticosteroid-free endoscopic and clinical outcomes in patients with Crohn's Disease - Week 48 analysis of the STARDUST trial European Crohn´s and Colitis Organisation - ECCO - OP35 Effect of maintenance ustekinumab on corticosteroid-free endoscopic and clinical outcomes in patients with Crohn's Disease - Week 48 analysis of the STARDUST trial](https://cm.ecco-ibd.eu/cmAbstractSubmission/Content/cmabstsms/EC21/abstracts/0000000270/0000739400/Images/3672_jan_ecco_abstract_cs_fig1.jpg)
European Crohn´s and Colitis Organisation - ECCO - OP35 Effect of maintenance ustekinumab on corticosteroid-free endoscopic and clinical outcomes in patients with Crohn's Disease - Week 48 analysis of the STARDUST trial
![PDF) O-01: IL-10 receptor dependent signals regulate the generation and function of anti-inflammatory macrophages in mice and humans PDF) O-01: IL-10 receptor dependent signals regulate the generation and function of anti-inflammatory macrophages in mice and humans](https://i1.rgstatic.net/publication/265338277_O-01_IL-10_receptor_dependent_signals_regulate_the_generation_and_function_of_anti-inflammatory_macrophages_in_mice_and_humans/links/5ffef3bc92851c13fe0c42aa/largepreview.png)
PDF) O-01: IL-10 receptor dependent signals regulate the generation and function of anti-inflammatory macrophages in mice and humans
![European Crohn´s and Colitis Organisation - ECCO - OP35 Effect of maintenance ustekinumab on corticosteroid-free endoscopic and clinical outcomes in patients with Crohn's Disease - Week 48 analysis of the STARDUST trial European Crohn´s and Colitis Organisation - ECCO - OP35 Effect of maintenance ustekinumab on corticosteroid-free endoscopic and clinical outcomes in patients with Crohn's Disease - Week 48 analysis of the STARDUST trial](https://cm.ecco-ibd.eu/cmAbstractSubmission/Content/cmabstsms/EC21/abstracts/0000000270/0000739400/Images/3672_jan_ecco_abstract_cs_fig2.jpg)